Skip to main content

Closed

PCSA: Processa Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

4thpctl

Volume

1.67×avg

Market Cap

5.95MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Processa Pharmaceuticals, Inc.

PCSANASDAQ Capital Market·USD·Closed

Processa Pharmaceuticals, Inc.

PCSANASDAQ·USD·Closed

$2.15

+5.39%

$2.15

+$0.11 (5.39%)

52W Range

4thpctl

Volume

1.67×avg

Mkt Cap

5.95MUSD

P/E

-0.2TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings